par 034
Pill imprint par 034 has been identified as Meclizine hydrochloride 12.5 mg.
Meclizine is used in the treatment of vertigo; motion sickness; nausea/vomiting and belongs to the drug class anticholinergic antiemetics. There is no proven risk in humans during pregnancy.
Meclizine 12.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Meclizine hydrochloride Images
- Imprint:
-
par
034 - Strength:
- 12.5 mg
- Color:
- Blue
- Size:
- 5.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
sodium starch glycolate type A potato
FD&C Blue No. 1
water
isopropyl alcohol
corn starch
stearic acid
magnesium stearate
silicon dioxide colloidal
- Drug Class:
- Anticholinergic antiemetics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- 49884-0034
More Meclizine Hydrochloride resources
- Meclizine
- Meclizine (Wolters Kluwer)
- Meclizine Chewable Tablets (Wolters Kluwer)
- meclizine (Cerner Multum)
- Meclizine Hydrochloride (AHFS DI)
- Meclizine (FDA)
- Meclizine (Wolters Kluwer)


